wdr5 in 6 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
wdr5 in 6
Wdr5 In 6, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wdr5+in+6/WDR5-IN-6/bio_rxiv__64898__2026__01__22__701194-211-38-54
Average 94 stars, based on 1 article reviews
Wdr5 In 6, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wdr5+in+6/WDR5-IN-6/bio_rxiv__64898__2026__01__22__701194-211-38-54
Average 94 stars, based on 1 article reviews
wdr5 in 6 - by Bioz Stars,
2026-09
94/100 stars
Images
1) Product Images from "SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma"
Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma
Journal: bioRxiv
doi: 10.64898/2026.01.22.701194
Figure Legend Snippet: a, Growth curves of SU-DIPGXIII cells transduced with shRNAs to knockdown both KAT2A and KAT2B, showing significantly reduced growth compared to control shRNA-transduced cells. b, Number of live SU-DIPGXIII+Cas9 cells expressing a control plasmid (HA/flag-GFP) or sgRNAs to KO SAGA-associated acetyltransferase activity ( TADA2B sgRNAs), or de-ubiquitinase activity ( ENY2 sgRNA). c, Schematic illustrating inhibition of histone-modifying modules of SAGA/ATAC complexes using chemical probes to target SAGA/ATAC-dependent histone acetylation (GSK4027, CPTH2, garcinol), SAGA-dependent H2A/H2B de-ubiquitination (USP22si-02), or WDR5-mediated H3K4me3 methylation (OICR-9529, WM856, WDR5-IN-4, and WDR5-IN-6). d, Average normalized cell viability from CellTiter-Glo assays conducted seven days after starting treatment of H3K27M mutant cells (teal curves) or non-transformed, H3 wildtype, control cells (black curves) with increasing doses of the KAT2A/2B bromodomain-targeting acetyltransferase inhibitor, GSK4027. e, Immunoblots confirming that treatment of BT245 cells with GSK4027 reduced H3K9ac in a dose-dependent manner, but not total H3 or SGF29 protein abundance. f-h, Dose response curves showing inhibition of H3K27M mutant DMG cell viability, but no effect on control H3 wild-type cells (black curves) following seven days of treatment with the DUB inhibitor, USP22i-S02 ( f, yellow curves), the WDR5 WIN site inhibitor, WDR5-IN-4 ( g, blue curves), or the WDR5 WBM site inhibitor, WDR5-IN-6 ( h, blue curves). i-j Average number of live SU-DIPGXIIIP*+ZsG/luc cells ( i ), and average BT245 ( j ) cell viability (CellTiter-Glo) following treatment with combinations of GSK4027 and USP22si-02 to simultaneously target both SAGA/ATAC-dependent histone acetyltransferase activity and SAGA-dependent H2A/H2B de-ubiquitination. k-l, BLISS synergy plots showing a combined effect of GSK4027 and WDR5-IN-6 treatment in reducing SU-DIPGXIIIP*+ZsG/luc growth ( k, **p<1.74×10 -3 ), and a combined effect of GSK4027 and WDR5-IN-4 treatment in reducing BT245 cell growth ( l , ****p<2.5×10 -10 ).
Techniques Used: Transduction, Knockdown, Control, shRNA, Expressing, Plasmid Preparation, Activity Assay, Inhibition, Ubiquitin Proteomics, Methylation, Mutagenesis, Transformation Assay, Western Blot, Quantitative Proteomics
Related Articles
Transduction:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Knockdown:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Control:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), shRNA:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Expressing:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Plasmid Preparation:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Activity Assay:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Inhibition:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Ubiquitin Proteomics:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Methylation:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Mutagenesis:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Transformation Assay:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Western Blot:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), Quantitative Proteomics:Article Title: SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma Article Snippet: Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.Small molecule inhibitors targeting various SAGA/ATAC-associated proteins or cholesterol synthesis enzymes were re-suspended in DMSO.. The following compounds were used in this study: SGF29-IN-1 (cat# HY-158009, MedChemExpress), GSK4027 (cat# SML2018, Sigma Aldrich), CPTH2 (cat# J65939LB0, ThermoFisher), garcinol (cat# 14076, Active Motif), USP22si-02 (cat# SML3875, Sigma Aldrich), WDR5-IN-4 (WIN site inhibitor, cat# HY-111753, MedChemExpress), |